Furthermore, Staudt et al. evaluated IgG columns with high affinity to the IgG3 (Therasorb®) autoantibody subclass as more effective in dilated cardiomyopathy than a Protein A column based strategy [20,21]. Here, IGHG3 is linked to dilated cardiomyopathy.